← Research & Industry News
External source
A first for CRISPR: powerful prime editing alters DNA directly in the human body
Application of the high-precision technique is part of a clinical trial to treat a genetic disease that can cause liver and nerve damage.
- Published by
- Nature
- Evidence type
- Clinical
Application of the high-precision technique is part of a clinical trial to treat a genetic disease that can cause liver and nerve damage.
This item was selected automatically by our daily literature and news monitor because it matches the topics we follow. Read the full story at Nature.
Let's engineer the next delivery breakthrough together
We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.
ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.